
    
      Lung cancer patients with newly diagnosed CNS metastasis with- at least one brain lesion
      measuring > 1 cm in longest dimension - not eligible for surgery or stereotactic
      radio-surgeryOpen-label, multicentre, national, randomised (1:1) phase II trialArm A: WBRT
      and Concurrent Gefitinib followed by Gefitinib Maintenance Arm B: Gefitinib
    
  